# NovelStem International Corp.: overview

NSTM · OTC · CIK 912544 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nstm.md) · [Financials](/companies/nstm/financials.md) · [Filings](/companies/nstm/filings.md) · [Insiders](/companies/nstm/insiders.md)

Latest reported revenue: [$140.0k](/filings/0001144204-13-057428.md) for Q3 FY2021, three months to 2013-09-30, from the 10-Q filed Oct 29, 2013 (XBRL us-gaap:SalesRevenueNet, accession 0001144204-13-057428).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [(0.05)](/filings/0001493152-25-021861.md) | not reported | [0.00](/filings/0001493152-26-023227.md) | [0.06](/filings/0001493152-26-038089.md) | not reported | not reported | [0.00](/filings/0001493152-26-023227.md) | [0.00](/filings/0001493152-26-038089.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [(0.02)](/filings/0001493152-24-012323.md) | [(0.09)](/filings/0001641172-25-003031.md) | [(0.07)](/filings/0001493152-26-012736.md) | [0.05](/filings/0001493152-26-012736.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nstm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FNY Investment Advisers, LLC](/funds/1742998.md) | 2026-06-30 | $0 | 25,000 |  | Unchanged |

## Recent filings

[All 227 filings](/companies/nstm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 11:11 ET | [10-Q](/filings/0001493152-26-038089.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038089 |
| 2026-05-15 | 18:27 ET | [10-Q](/filings/0001493152-26-023227.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023227 |
| 2026-03-26 | 18:40 ET | [10-K](/filings/0001493152-26-012736.md) | Annual report, period 2025-12-31 | 0001493152-26-012736 |
| 2025-11-12 | 14:39 ET | [10-Q](/filings/0001493152-25-021861.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021861 |
| 2025-08-06 | 17:18 ET | [10-Q](/filings/0001493152-25-011661.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011661 |
| 2025-05-19 | 17:19 ET | [10-Q](/filings/0001641172-25-011514.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011514 |
| 2025-04-07 | 17:24 ET | [10-K](/filings/0001641172-25-003031.md) | Annual report, period 2024-12-31 | 0001641172-25-003031 |
| 2024-11-14 | 16:09 ET | [10-Q](/filings/0001493152-24-045856.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045856 |
| 2024-08-14 | 17:07 ET | [10-Q](/filings/0001493152-24-032378.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032378 |
| 2024-05-15 | 14:38 ET | [10-Q](/filings/0001493152-24-019729.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019729 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-012736.md), filed Mar 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 912544
- Tickers: NSTM
- Exchange: OTC
- SIC code: 5990 Retail-Retail Stores, NEC
- State of incorporation: FL
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.
